EUVIMEDObjevte EUVIMED
Scoping ReviewOpen access · CC BY-NC 4.0

First‐trimester biomarkers of gestational diabetes mellitus: A scoping review

May Swinburne iD, Samuel Krasner iD, Sam Mathewlynn, Sally Collins

Acta Obstetricia et Gynecologica Scandinavica · 2025-10 · 104 (10) · 1838-1848

DOI: 10.1111/aogs.70046 ↗

At a glance

Scoping Review in Acta Obstetricia et Gynecologica Scandinavica, published online on 2025-08-29. Written by May Swinburne and 3 co-authors. Institution: Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK. Major MEDLINE topics: Diabetes, Gestational, Pregnancy Trimester, First. Cited 19 times so far (Crossref); 112 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Gestational diabetes mellitus (GDM) affects approximately 14% of pregnancies globally, with rising incidence depending on the diagnostic criteria used. In the UK, screening relies on risk factors at booking, followed by a diagnosis via an oral glucose tolerance test in the second trimester. This approach may lack sensitivity and has poor tolerability. Emerging evidence suggests that GDM pathophysiology begins in the first trimester, with biomarkers showing potential for early prediction. Identifying these could enable earlier risk stratification, improved diagnostic pathways, and better maternal–fetal outcomes. This scoping review maps the existing literature on first‐trimester biomarkers of GDM to evaluate their clinical utility and integration into predictive models. A literature search was conducted using Medline, Embase, and PubMed to identify studies on first‐trimester biomarkers of GDM. Inclusion criteria included (1) studies investigating biomarkers at

Subjects

MeSH terms (MEDLINE)

Diabetes, GestationalPregnancy Trimester, FirstHumansPregnancyFemaleBiomarkersGlucose Tolerance Test

Author keywords

first biomarkers PAPP‐A (pregnancy‐associated plasma protein‐a) PlGF (placental…gestational diabetes mellitus pregnancy trimester

Substances

Biomarkers

Authors and institutions

  • Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
  • Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Birmingham Women and Children's NHS Foundation Trust, Birmingham, UK.

ORCID profiles: May Swinburne, Samuel Krasner

Cite

APA

Swinburne, M., Krasner, S., Mathewlynn, S., & Collins, S. (2025). First‐trimester biomarkers of gestational diabetes mellitus: A scoping review. Acta Obstetricia et Gynecologica Scandinavica, 104(10), 1838-1848. https://doi.org/10.1111/aogs.70046

Vancouver

Swinburne M, Krasner S, Mathewlynn S, Collins S. First‐trimester biomarkers of gestational diabetes mellitus: A scoping review. Acta Obstetricia et Gynecologica Scandinavica. 2025;104(10):1838-1848. doi:10.1111/aogs.70046

BibTeX
@article{Swinburne2025,
  author = {Swinburne, May and Krasner, Samuel and Mathewlynn, Sam and Collins, Sally},
  title = {First‐trimester biomarkers of gestational diabetes mellitus: A scoping review},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  volume = {104},
  number = {10},
  pages = {1838--1848},
  doi = {10.1111/aogs.70046}
}
Start for free →